Director, Molecular Biomarker Lab Operations

BioSpace; Indianapolis (IN); Sur place; USD 153 000 - 264 000; Plein temps

Résumé du poste

Lilly in Indianapolis seeks a Laboratory Operations & Analytical Sciences Lead for its Cardiometabolic Translation & Biomarker Research (CTBR). You will coordinate day-to-day biomarker lab operations across clinical chemistry, mass spectrometry, and multiplex immunoassay platforms, while mentoring staff and driving quality and data integrity.

The role partners with discovery biology and clinical science teams to define biomarker needs, scale capabilities, and ensure compliant, reproducible

Qualifications

• Ph.D. in analytical chemistry, biochemistry, biology or related field.
• Leadership of people, projects or laboratory operations.
• Experience with clinical chemistry analyzers and multiplex immunoassay platforms is valued.

Responsabilités

• Lead laboratory operations to ensure seamless biomarker studies across capabilities.
• Mentor and develop laboratory staff and coordinate cross-capability work.
• Support quality, data integrity, and regulatory compliance (GCP/GCLP/CLIA).
• Provide technical leadership for assay qualification and troubleshooting across platforms (Roche Cobas, LC-MS/MS, ELISA).
• Develop translational biomarker strategies and interpret data in clinical context.
• Standardize laboratory processes and integrate data across capabilities.

Connaissances

Leadership

Project management

Mentoring

Collaboration

Compliance awareness

Formation

Ph.D. in analytical chemistry/biochemistry/biology or related

Outils

Roche Cobas analyzers

MS/MS platforms (MSD/Luminex/Olink)

LC-MS/MS

GC-MS

ELISA/MSD

Description du poste

Lilly in Indianapolis seeks a Laboratory Operations & Analytical Sciences Lead for its Cardiometabolic Translation & Biomarker Research (CTBR). You will coordinate day-to-day biomarker lab operations across clinical chemistry, mass spectrometry, and multiplex immunoassay platforms, while mentoring staff and driving quality and data integrity.

The role partners with discovery biology and clinical science teams to define biomarker needs, scale capabilities, and ensure compliant, reproducible